<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2172">
 <bold>Introduction:</bold> Nasal high flow oxygen (NHFO) is an attractive therapy for acute hypoxemic respiratory failure (AHRF), with reported comfort, and theoretical wash-out of CO2 and generation of PEEP. However, its clinical efficacy is uncertain. We undertook a systematic review of current evidence to support its use in adults.
</p>
